MedPath

Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer

Conditions
Predictive Cancer Model
Interventions
Other: Radiomic Algorithm
Registration Number
NCT04511481
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Brief Summary

Platinum-sensitive is an important basis for the treatment of recurrent epithelial ovarian cancer (EOC) without effective methods to predict.We aimed to develop and validate the EOC deep learning system to predict the platinum-sensitive of EOC patients through analysis of enhanced magnetic resonance imaging (MRI) images before initial treatment.Ninety-three EOC patients received platinum-based chemotherapy (\>= 4 cycles) and debulking surgery from Sun Yat-sen Memorial Hospitalin China from January 2011 to January 2020 were enrolled. This deep-learning EOC signature achieved a high predictive power for platinum-sensitive, and the signature based on MRI whole volume is better than that on primary tumor area only.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
93
Inclusion Criteria
  • (1)Patients with epithelial ovarian cancer (2 )Patients received platinum-based chemotherapy (>= 4 cycles) and debulking surgery
Exclusion Criteria
  • Patients with epithelial ovarian cancer received less than 4 cycles platinum-based chemotherapy or no debulking surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
platinum-resistant groupRadiomic Algorithm-
platinum-sensitive groupRadiomic Algorithm-
Primary Outcome Measures
NameTimeMethod
Platinum sensitivity9 years

Platinum sensitivity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sun Yat-Sen Memorial Hospital of Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath